about
Surfactant protein A genetic variants associate with severe respiratory insufficiency in pandemic influenza A virus infection.[Low adherence to 2009 pandemic influenza A(H1N1) vaccination program among health care workers of a medical centre during the pandemic phase].Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patientsImpact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study.Mannose-binding lectin gene variants and infections in patients receiving autologous stem cell transplantationQuinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts.Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia.Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections.Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort studyEffect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial.Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in menImproved diagnosis of orthopedic implant-associated infection by inoculation of sonication fluid into blood culture bottlesEvaluation of inflammatory and renal-injury markers in women treated with antibiotics for acute pyelonephritis caused by Escherichia coli.Association between mannose-binding lectin deficiency and septic shock following acute pyelonephritis due to Escherichia coliSonication versus vortexing of implants for diagnosis of prosthetic joint infection.Prosthesis failure within 2 years of implantation is highly predictive of infectionIntra- and inter-species spread of carbapenemase genes in a non-hospitalized patient.Conventional and molecular diagnostic strategies for prosthetic joint infections.Future alternatives for the treatment of infections caused by carbapenemase-producing Enterobacteriaceae: what is in the pipeline?Drug treatments for prosthetic joint infections in the era of multidrug resistance.Clinical experience with the use of daptomycin in a tertiary care teaching hospital in Barcelona, Spain.Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology.Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).Novel MASP2 variants detected among North African and Sub-Saharan individuals.Inappropriate use of antibiotics in hospitals: the complex relationship between antibiotic use and antimicrobial resistance.Enterococcal bloodstream infection. Design and validation of a mortality prediction rule.Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate.Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study.Community-acquired febrile urinary tract infection in diabetics could deserve a different management: a case-control study.A nosocomial outbreak of influenza during a period without influenza epidemic activity.Characterization and rapid control of a vancomycin-resistant Enterococcus faecium (VREF) outbreak in a renal transplant unit in Spain: The environment matters.Clinical characteristics, treatment and outcomes of MRSA bacteraemia in the elderly.Optimization of pre-emptive isolations in a polyvalent ICU through implementation of an intervention strategy.Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study.Pharmacokinetics of micafungin in patients with pre-existing liver dysfunction: A safe option for treating invasive fungal infections.Risk factors for severe sepsis in community-onset bacteraemic urinary tract infection: impact of antimicrobial resistance in a large hospitalised cohort.Health Care-Associated Infective Endocarditis: a Growing Entity that Can Be Prevented.Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.Globally expanding carbapenemase finally appears in Spain: nosocomial outbreak of acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain.Advantages of sonication fluid culture for the diagnosis of prosthetic joint infection.
P50
Q30363831-5277E431-F305-409D-A9B5-C77C96F30662Q30399929-03513C48-1DFF-452B-8EC9-2397BAECC221Q30406140-0CD5EE69-AFF5-4373-8EE7-ABEBF77557A3Q31102336-89C4C806-770B-4225-9B49-BDFB13A858BEQ33579788-C8AF53F8-0368-4356-B5BF-EB2B93A0D26DQ33856263-E85E629A-5BC7-43E4-9947-E39A26676ADCQ34175100-0DBF1950-0364-4292-B2D7-73AF49876483Q34231302-EF9DD95A-9711-4AC7-A169-D7107B095A4DQ34389008-BA4FD3F2-CEDC-4AF3-91C3-8614B2C77447Q34451794-B44292BA-506D-4C44-901C-18604611E279Q34990251-D526B48D-DE7B-44BA-8F45-8DB9E6D8C789Q35455324-76E40F92-CEDA-42AD-8C1F-DBA43CD3FE88Q35542067-49608AAE-85B8-4B17-8675-021CACF01285Q35690047-8775F62A-2D05-404D-954A-4CDFDBE77455Q36558988-B476CEDB-7F62-4245-9177-47C6AE8AE815Q37219601-45A31608-419D-45E9-81E4-CEBAD60D6DE5Q37864965-3DE4CC47-8B38-47CA-B564-DB4F4010D398Q38168886-4F65A8D4-E510-4FF1-952E-5F2CAE8DCCD1Q38301162-5E4F9DA4-FC0C-4C37-AA85-A3D215915021Q38800556-6038FBC0-8950-425F-9367-B67582AC225BQ38990504-14A59888-0AE1-4D27-B196-F6D5556C3167Q39054376-2D1F1E67-1C58-47D2-A309-521EC6C1BEDDQ39063637-02393386-6D1B-46EA-8804-A3FC6E00AF3AQ39191618-B376DF35-752A-4F58-857E-E657ACE83DADQ39332044-6C2055A6-9ED6-48A9-A5FC-E81CEC1BDD56Q40053444-E995EBAE-EFCD-42A7-9C54-DFDC59049F77Q40356202-BD1EB6A3-BDF9-4A17-A047-62B12EFE73E5Q40528587-444AEA95-DFF4-4DEF-8FC6-DA2CFEC6DDE1Q40551854-BA62E194-E7EE-4A22-91A4-EB41208A16D9Q40564570-FC3CF818-D0EE-4212-9200-AC0E9F540925Q40683485-25C28791-DA58-4A23-8B65-831FFABA5AC2Q40848041-D79E6CCC-E753-4D4A-B0AA-9BB0370B3E73Q41178964-D50FFC36-703E-4166-AA9F-D1C25561F801Q41325788-59C20E0C-D7C6-48AA-8B4F-EDCC1DD5ACEAQ41326325-DB30429C-4B06-4CC2-9373-9416732924CAQ41705403-125075AE-F7B9-43A2-830C-3C6B529CD2C8Q41735650-8807AF46-D3B6-47CC-A98A-4AE1CEEBEF65Q41741402-EAE1D353-B43A-4A00-BB97-8F1DBD4A3F57Q41918992-4CB7AB1E-E83B-4D97-8E3A-9B0F5D862A9CQ42223857-047DA1A4-C368-4853-A34C-C5C814F4C34C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Juan Pablo Horcajada
@ast
Juan Pablo Horcajada
@en
Juan Pablo Horcajada
@es
Juan Pablo Horcajada
@nl
Juan Pablo Horcajada
@sl
type
label
Juan Pablo Horcajada
@ast
Juan Pablo Horcajada
@en
Juan Pablo Horcajada
@es
Juan Pablo Horcajada
@nl
Juan Pablo Horcajada
@sl
altLabel
J Horcajada
@en
JP Horcajada
@en
Juan Horcajada
@en
Juan P. Horcajada
@en
prefLabel
Juan Pablo Horcajada
@ast
Juan Pablo Horcajada
@en
Juan Pablo Horcajada
@es
Juan Pablo Horcajada
@nl
Juan Pablo Horcajada
@sl
P106
P1153
7004469799
P21
P31
P496
0000-0001-9873-5459